The immunoproteasome-specific inhibitor ONX 0914 reverses susceptibility to acute viral myocarditis
Open Access
- 1 February 2018
- journal article
- research article
- Published by Springer Science and Business Media LLC in EMBO Molecular Medicine
- Vol. 10 (2), 200-218
- https://doi.org/10.15252/emmm.201708089
Abstract
Severe heart pathology upon virus infection is closely associated with the immunological equipment of the host. Since there is no specific treatment available, current research focuses on identifying new drug targets to positively modulate predisposing immune factors. Utilizing a murine model with high susceptibility to coxsackievirus B3-induced myocarditis, this study describes ONX 0914-an immunoproteasome-specific inhibitor-as highly protective during severe heart disease. Represented by reduced heart infiltration of monocytes/macrophages and diminished organ damage, ONX 0914 treatment reversed fulminant pathology. Virus-induced immune response features like overwhelming pro-inflammatory cytokine and chemokine production as well as a progressive loss of lymphocytes all being reminiscent of a sepsis-like disease course were prevented by ONX 0914. Although the viral burden was only minimally affected in highly susceptible mice, resulting maintenance of immune homeostasis improved the cardiac output, and saved animals from severe illness as well as high mortality. Altogether, this could make ONX 0914 a potent drug for the treatment of severe virus-mediated inflammation of the heart and might rank immunoproteasome inhibitors among drugs for preventing pathogen-induced immunopathology.Funding Information
- Deutsche Forschungsgemeinschaft (DFG VO 1602/4‐1, DFG KA 1797/7‐1)
- Deutsches Zentrum für Herz-Kreislaufforschung
This publication has 65 references indexed in Scilit:
- Mice completely lacking immunoproteasomes show major changes in antigen presentationNature Immunology, 2011
- A Molecular Mechanism for Bacterial Susceptibility to ZincPLoS Pathogens, 2011
- Impairment of Immunoproteasome Function by β5i/LMP7 Subunit Deficiency Results in Severe Enterovirus MyocarditisPLoS Pathogens, 2011
- The Emerging Role of Innate Immunity in the Heart and Vascular SystemCirculation Research, 2011
- Unexpected Role for the Immunoproteasome Subunit LMP2 in Antiviral Humoral and Innate Immune ResponsesThe Journal of Immunology, 2010
- Neutrophil Extracellular Traps: How to Generate and Visualize ThemJournal of Visualized Experiments, 2010
- Differential Interferon Responses Enhance Viral Epitope Generation by Myocardial Immunoproteasomes in Murine Enterovirus MyocarditisThe American Journal of Pathology, 2009
- The Mitogen-Activated Protein Kinase (MAPK)-Activated Protein Kinases MK2 and MK3 Cooperate in Stimulation of Tumor Necrosis Factor Biosynthesis and Stabilization of p38 MAPKMolecular and Cellular Biology, 2007
- Ongoing Coxsackievirus Myocarditis Is Associated with Increased Formation and Activity of Myocardial ImmunoproteasomesThe American Journal of Pathology, 2006
- Bortezomib or High-Dose Dexamethasone for Relapsed Multiple MyelomaThe New England Journal of Medicine, 2005